US 10500238
Use of gram negative species to treat atopic dermatitis
granted A61KA61K35/74A61K9/0014
Quick answer
US patent 10500238 (Use of gram negative species to treat atopic dermatitis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K35/74, A61K9/0014, A61K9/06, A61P